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Development of Dual Anti-biofilm and Anti-bacterial Medical 
Devices
Laurence Burroughs, a Waheed Ashraf, b Sonali Singh, c Luisa Martinez-Pomares, c Roger Bayston, b Andrew L. Hook *a 
The rising occurrence of antimicrobial resistance demands new strategies for delivering antibiotics to ensure their effective 
use. In this study, a multi-functional strategy to address medical device associated infections is explored whereby an anti-
attachment and an antibacterial mechanism have been combined. Silicone catheters impregnated with multiple antibiotics 
are coated with polyacrylate coatings previously shown to reduce bacterial attachment and biofilm formation. Antibiotics 
are delivered through the applied coating and the delivery rate depends on the coating thickness and chemistry. Coated 
devices achieve a zone of inhibition and TK100 to gram-negative Escherichia coli and gram-positive Staphylococcus aureus 
similar to those of uncoated devices, whilst maintaining anti-attachment properties. No adverse immunological responses 
of the coatings were observed. The multi-functional nature of the device developed in the study represents an important 
approach to combatting medical device associated infections.
Introduction
Antibiotic resistance is rising to dangerous levels in all areas of 
the world, decreasing the effectiveness of disease treatments 
and placing increasing pressure on the global health system.1 
One issue reducing the efficacy of antibiotic treatments is 
biofilm formation; after adhering to a surface, planktonic 
bacteria form biofilms, which are up to 1000 times less 
susceptible to antimicrobial treatments and host defences.2 
Around 80% of healthcare-acquired infections are believed to 
be associated with biofilm formation, with catheter-associated 
urinary tract infections (CAUTIs) one of the most common 
infections found in patients.2-3 The duration of catheterisation 
has a direct influence on the likelihood and type of infection, 
with treatment considerations often varying between long-
term (> 28 days) and short-term catheter infections.3b Long-
term, indwelling catheterisation can be required in cases of 
chronic debilitating illness with loss of mobility, such as multiple 
sclerosis, or in patients with a condition affecting nerves that 
control the bladder, such as spinal injury. The daily risk of 
bacterial colonisation when an indwelling catheter is in place is 
3-7%; patients requiring extended catheter use are therefore at 
high risk of bacterial infection and those with chronic indwelling 
catheters are assumed to be bacteriuric.3b
Development and implementation of novel biomaterials 
able to resist biofilm formation is an attractive target for use in 
a variety of biomedical applications including urinary catheters. 
A range of synthetic polymeric materials able to resist bacterial 
attachment have been reported including zwitterionic polymers 
and polymeric ammonium salts,4 poly(ethylene glycol)5 and 
polyglycerols,6 and polyacrylates and polymethacrylates.7 In 
particular, polyacrylates with molecular stiff hydrophobic 
pendant groups offer broad spectrum resistance to biofilm 
formation,8 which has also been demonstrated in vivo.7b The 
mechanism by which these materials prevent bacterial biofilm 
has not yet been established, however, the polymers do not kill 
bacteria and the importance of a bulky hydrophobic moiety 
suggests possible interactions with the lipophilic cell wall or 
preferential adsorption of hydrophobic biomolecules that 
mediate the biological response.7-8 These materials can be 
engineered as flexible coatings adhered to silicone such that 
they are suitable for use with urinary catheters.9 However, 
these materials have yet to be shown to resist biofilm formation 
for long-term periods of 28 days or more. 
An alternative approach to developing anti-biofilm coatings involves 
the release of antimicrobials from impregnated materials. 
Antiseptics such as chlorhexidine10 and silver containing compounds 
have been employed;11 however, toxicity issues and limited evidence 
of efficacy question the viability of these approaches.12 McCoy et al. 
developed a pH-responsive antimicrobial release system using 
polymerised drug conjugates in an effort to extend the therapeutic 
release time beyond that often observed with diffusion-controlled 
release.13 However, such an approach restricts use to a narrow range 
of infections, and efficacy may be decreased in complex cases. 
Bayston et al. developed a method to impregnate silicone catheters 
with multiple antimicrobials. This methodology successfully 
prevented colonisation by a wide range of pathogens for over 12 
weeks.3a, 14 
We hypothesised that this approach, used in conjunction with 
polyacrylate coatings resistant to biofilm formation, would allow for 
the development of infection-resistant devices with reduced 
dependence on antimicrobials and optimised antimicrobial release 
profiles suitable for long-term use. Hence, the coating would both 
prevent biofilm formation and control the release of antimicrobials. 
Here, the coating would be intended to prevent formation of biofilm 
on a urinary catheter rather than for the treatment of established 
urinary tract infections.
tBCHA
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Figure 1. a-d) Monomers used in the study (cLogP calculated using 
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Figure 2. a) Representative SEM image of the cross-sectional view of 
a coated catheter showing coating thickness. b) Measured coating 
thickness for all four polymers using a polymer solution 
concentration of 1% (w/v). Scale bars equal one standard deviation, 
n = 5.
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Figure 3. a-b) Representative fluorescence images of bacterial 
coverage measured on a) uncoated PDMS and b) p-tBCHA coated 
samples. c) S. aureus coverage after 72 h culture with uncoated and 
polymer coated catheters. Bacteria were stained with SYTO64 (Ex = 
599 nm, Em = 619 nm) and imaged by confocal microscopy. Average 
of 4 technical replicates taken from two biological replicates, N = 2. 
Error bars equal ± 1 standard deviation unit. 
Silicone
catheter
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and rinsed Drying
Polymer
coating
Figure 4. Schematic depiction of the production of coated and 
impregnated catheters.
Results and Discussion
Validation of anti-biofilm performance
Four monomers of varying hydrophobicity were polymerised using 
thermally-initiated free-radical polymerisation to provide a 
homopolymer library of coatings (Figure 1); two of these polymers, 
poly-tert-butyl cyclohexyl acrylate (p-tBCHA, Figure 1a) and poly-
ethylene glycol dicyclopentyl ether acrylate (p-EGDPEA, Figure 1b), 
have been previously shown to resist biofilm formation, whilst poly-
di(ethylene glycol) methyl ether methacrylate (p-DEGMA, Figure 1c) 
and poly-2-hydroxy-3-phenoxypropyl acrylate (p-HPhOPA, Figure 1d) 
both supported biofilm formation.7b The four polymers were 
selected due to their range in hydrophobicity, with calculated logP 
(cLogP) values varying from 0.89 to 4.7 (Figure 1). Successful 
polymerisation of the monomers was confirmed by NMR (Figure SI1-
3)
Initially the anti-biofilm nature of the silicone sections coated with 1 
wt% solutions of each polymer was assessed. Coating thickness was 
measured by SEM to be 0.5-3 μm (Figure 2). Variations in coating 
thickness are likely due to viscosity differences between the different 
polymer solutions.15 Samples were incubated with S. aureus for 72 h 
before staining with SYTO64 and imaging by confocal microscopy. 
Samples were assessed with S. aureus as this species produced 
higher surface coverages of bacterial biofilm on uncoated plain 
catheters (45.9 ± 22.5%) compared with E. coli (3.6 ± 3.1%). The 
bacterial biofilm coverages measured on each coating are shown in 
Figure 3. A statistically significant (p < 0.0001) reduction in bacterial 
coverage of > 97% was observed on the coatings of p-tBCHA and p-
EGDPEA compared with the uncoated catheters. This was consistent 
with previous observations for these coatings,7 suggesting that the 
coating methodology maintained the anti-biofilm properties. The p-
DEGMA coating also significantly (p=0.002) reduced the bacterial 
coverage by 73% compared with the uncoated sample, whilst the 
bacterial coverage on the p-HPhOPA coating was not statistically 
different from the uncoated catheter samples.
Antimicrobial Delivery Experiments
Next, the delivery of antimicrobials through a polymer coating and 
how polymer hydrophobicity influenced antimicrobial release was 
investigated. Silicone catheter sections were impregnated with the 
antimicrobials rifampicin, sparfloxacin and triclosan according to a 
previously published procedure.16 Improved prevention of biofilm 
formation and emergence of resistant strains has previously been 
demonstrated when using multiple antimicrobials compared with a 
single drug.3a, 14c These compounds were chosen due to their activity 
against CAUTI pathogens and chemical compatibility with the 
impregnation procedure.14b Rifampicin was included because of its 
activity alone and in combination against staphylococci and its 
synergistic activity against many mutlidrug-resistant gram negative 
bacteria.17 Sparfloxacin has been withdrawn from the market as it 
has been overtaken by other quinolone antimicrobials, but it is still 
available for medical applications, is active against CAUTI pathogens 
and is safe for use in the lower and upper urinary tracts.18 Triclosan 
is approved for use in medicinal products within the EU and by the 
FDA and is a component of Vicryl Plus surgical sutures.19 The 
impregnated catheter sections were dip-coated 3 times in a 1-5 wt% 
polymer in toluene solution and dried for 24 h under vacuum (Figure 
4). Non-impregnated plain silicone catheter controls were also dip-
coated similarly using the four polymer solutions.
Serial plate transfer tests were carried out for 10 days on the coated, 
impregnated catheters using plates inoculated with Staphylococcus 
aureus (S. aureus) and Escherichia coli (E. coli) and compared to the 
uncoated impregnated control (Figure 5). All four polymer coatings 
showed zones of inhibition for both bacterial species indicating that 
antimicrobials could be successfully delivered through a 
poly(meth)acrylate coating. However, the zones of inhibition were 
reduced relative to that of the impregnated catheters without a 
polymer coating. No correlation between the cLogP of the monomer, 
as a measure of hydrophobicity,8a, 8c and zone of inhibition size could 
be seen (see Figure SI4). Coatings of p-tBCHA prepared using a 5 wt% 
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solution did not achieve a zone of inhibition with E. coli, however, 
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 No coating  p-tBCHA  p-EGDPEA  p-DEGMAp-HPhOPA
Figure 5. Assessment of the zone of inhibition for antimicrobial 
impregnated catheters with a-e), E. coli and f-j) S. aureus for a and f) 
no coating, b and g) p-tBCHA, c and h) p-EGDPEA, d and i) p-DEGMA, 
and e and j) p-HPhOPA. Photographs after 1 day. Samples located in 
90 mm petri dishes. k) 10 day serial plate transfer, E. Coli l) 10 day 
serial plate transfer, S. aureus. Error bars equal ± one standard 
deviation unit, N = 3. 
0 24 48 72
1
10
100
1000
10000
100000
1000000
cf
u/
m
L
Hours
0 24 48 72
1
10
100
1000
10000
100000
1000000
10000000
cf
u/
m
L
Hours  
 Uncoated impregnated  p-tBCHA  p-EGDPEA  p-DEGMA 
p-HPhOPA  Uncoated plain catheter
Figure 6. Assessment of the ability of catheters impregnated with 
antimicrobials and coated with different polymers to kill associated 
bacteria. a) tK100 for impregnated catheters b) tK100 for catheters 
without impregnated antimicrobials. Error bars equal ± one 
standard deviation unit, N = 3.
reducing the solution concentration to 1 wt% achieved a zone of 
inhibition of ≈ 90% of an uncoated catheter (Figure SI5). 
Next, a series of assays of the time taken to kill 100% of attached 
E. coli (tK100) were carried out on the coated catheters to determine 
whether the coatings were still able to kill all attached bacteria 
(Figure 6a). The attached bacteria on the catheters coated with p-
DEGMA or p-HPhOPA were reduced after 24 h but could not be taken 
to < 1 Log10 cfu/mL after 72 h, suggesting that antimicrobial 
permeability through these coatings was reduced. Catheters coated 
with p-EGDPEA and p-tBCHA were both able to reach < 1 Log10 cfu/ml 
after 72 h. In comparison, the uncoated impregnated catheter 
reached < 1 Log10 cfu/mL viability at 48 h. There was no difference in 
viability between plain silicone catheter and plain silicone catheter 
coated with the polymers (Figure 6b). Thus, the coatings that were 
more hydrophobic showed increased permeation of the 
antimicrobials compared with the more hydrophilic coatings despite 
an increased or similar thickness (Figure 2b). No significant 
difference in the amount of bacteria on the different coatings was 
observed in the absence of impregnated anti-microbials, despite the 
different chemistries producing significantly different amounts of 
biofilm formation.7 Thus, the polyacrylate coatings did not prevent 
association with planktonic bacteria, which is consistent with the 
mode of action of these polymers acting specifically on biofilm 
formation and not involving a killing mechanism. 
Quantification of Antimicrobial Release
With the initial bacterial studies indicating a reduction in 
antimicrobial release through the polymer coatings, we next 
quantified drug elution from the catheters. The catheter sections 
were immersed in deionised water for 48 h at 37°C and the solution 
analysed by liquid chromatography mass spectrometry (LC-MS). The 
percentage of drug elution (Figure SI7-13) was normalised relative to 
the uncoated impregnated catheter set at 100% and plotted against 
cLogP (Figure 7). No monomer or coating oligomers were detected 
in the analysed solutions suggesting that the coating was stable in 
the aqueous environment over 48 h. Antimicrobial release was 
achieved through all four polymer coatings although at a reduced 
quantity as compared with the uncoated impregnated catheter. The 
smallest reduction for all three antibiotics was observed for the 
coating of tBCHA, where 43%, 97% and 90% of sparfloxacin, triclosan 
and rifampicin was released, respectively, compared with the 
uncoated catheter (Figure 7a-c). p-HPhOPA exhibited the greatest 
reduction in sparfloxacin release, with 15 µg/mL detected compared 
to 91 µg/mL for the uncoated sample (Figure 7a). For the other 
coated samples a range of 24-39 µg/mL detected concentration was 
observed. p-DEGMA showed the greatest reduction in triclosan 
release, with 50 µg/mL detected compared to 78 µg/mL detected for 
the uncoated catheter (Figure 7b). A correlation between cLogP and 
percentage elution of triclosan was seen, suggesting that 
intermolecular interactions between the antibiotic and the polymers 
may play a role in the drug elution (Figure 7b and d). Rifampicin 
release was most affected by the p-DEGMA coating; in 2 out of 3 
repeats, the level of rifampicin was shown to be below the limit of 
detection on the LC-MS system, making the detected level 
statistically non-significant (Figure 7c). The other 3 coatings exhibited 
a reduced effect on rifampicin release, delivering around 1.3 µg/mL 
versus the uncoated sample at 1.5 µg/mL.
These results were consistent with the tK100 tests, where only p-
tBCHA and p-EGDPEA coatings were able to reach < 1 Log10 cfu/ml 
after 72 h (Figure 6a). p-tBCHA showed the greatest level of detected 
drug elution using LC-MS with all 3 antimicrobials, possibly due to 
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reduced intermolecular interactions between the antibiotics 
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 Figure 7. LC-MS assessment of the antimicrobial release from impregnated catheters through different polymer coatings. a) Sparfloxacin 
drug elution, b) triclosan drug elution, c) rifampicin drug elution, d) Percentage of drugs eluted through coatings relative to uncoated catheter 
against cLogP. The line of best fit and associated coefficient of determination (R2) is shown for each antibiotic: triclosan (green), sparfloxacin 
(yellow) and rifampicin (orange).  Error bars equal ± 1 standard deviation unit, n = 3. 
and the polymer. The p-tBCHA coating was thicker than the other 
samples (Figure 2b), which was anticipated to impede antimicrobial 
release. Counter to this, relatively high drug release was observed 
through the p-tBCHA coating compared with the other samples 
(Figure 7), thus, it was likely that intermolecular interactions rather 
than coating thickness played the key role in determining drug 
elution through the samples studied. It is important to note that the 
zone of inhibition and tK100 tests were not carried out with the 
catheter sections fully immersed in solution, which may result in less 
coating swelling and consequently more restricted drug elution. 
There was no strong correlation between cLogP and elution of 
rifampicin or sparfloxacin (R2 = 0.41 and R2 = 0.50 respectively, Figure 
7d); in contrast, triclosan elution showed a strong correlation to 
cLogP (R2 = 0.95, R2(adj) = 0.92, p = 0.03, Figure 7d) It is possible that 
the bulkier molecules are more affected by the polymer network 
than triclosan, making hydrophobicity of the coating less of a factor 
determining release.
Coating Characterisation
Time of flight secondary ion mass spectrometry (ToF-SIMS) depth 
profiling analysis, using an Ar-cluster sputter beam at 10 keV with Bi3+ 
primary beam at 25 keV over a random raster area, was then used to 
assess the depth distribution of the coating and antimicrobials within 
the coated, impregnated devices. Molecular ions for all 3 
antimicrobials could be detected; rifampicin (M+H+ = C43H59N4O12) at 
823.4, sparfloxacin (M+H+ = C19H23F2N4O3) at 393.2 and triclosan 
(M+H+ = C12H8Cl3O2) at 289.0, whilst characteristic ions for p-tBCHA 
(C4H9+), p-EGDPEA (C5H7+), p-DEGMA (C3H7O+) and p-HPhOPA (C6H5+) 
were also identified.20 Both the p-tBCHA and p-EGDPEA coatings 
appeared to have a lower intensity of antimicrobial ions in the 
polymer coating, which increased to a maximum at the interface 
between the coating and silicone catheter before decreasing again 
(Figure 8a-b). The more hydrophilic polymer coatings p-DEGMA and 
p-HPhOPA appeared to have greatest intensity of antimicrobial 
peaks in the coating, which then decreased in line with the coating 
ion intensities (Figure 8c-d). It is possible that during the coating 
procedure more of the impregnated antimicrobials leach out into the 
polymers p-DEGMA and p-HPhOPA than p-tBCHA and p-EGDPEA. 
This may also account for the observed discrepancy between the 
zone of inhibition and tk100 tests and the detected drug elution in 
the LC-MS studies; if the rate of drug elution through the polymers 
differs between samples, then an increased initial concentration of 
drug in the coating may produce a greater biological response. The 
uncoated impregnated sample showed uniform antimicrobial 
distribution through the profiled area (see Figure SI14-16).
Biocompatibility Studies
The components of the dual anti-biofilm anti-microbial device have 
previously been demonstrated to not be cytotoxic.17-20 To further 
assess the biocompatibility of polymer coatings, primary human 
monocyte-derived macrophages were incubated with the coated or 
uncoated plain or antibiotic-impregnated catheters for 24 h. The 
effect of polymer coatings on macrophage function was assessed by 
stimulating these cells with lipopolysaccharide (LPS) for a further 24 
h. Cell viability before and after LPS addition was determined by 
measuring the amount of lactate dehydrogenase in the cell 
supernatants (Supporting Information). None of the coatings tested 
appeared to increase cell death appreciably compared to a 
macrophage only control (no catheter condition). 
To determine the effect of the coatings on immune cell function, 
the production of two pro-inflammatory cytokines: tumour necrosis 
factor alpha (TNF-α) and interleukin 6 (IL-6), by macrophages was 
also measured before and after addition of LPS (Figure 9a). 
Macrophages did not produce the pro-inflammatory cytokines TNF-
c) d)
a) b)
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α or IL-6 when incubated with coated or uncoated plain catheters alone, i.e. in “unstimulated samples” (Figure 9b-c). Thus, the 
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 p-DEGMA [C3H7O]+  silicone [Si2C5H15O]+  triclosan [C12H8O2Cl3]+
 rifampicin [C43H59N4O12]+  sparfloxacin [C19H23N4O3F2]+
 p-HPhOPA [C6H5]+  silicone [Si2C5H15O]+  triclosan [C12H8O2Cl3]+
 rifampicin [C43H59N4O12]+  sparfloxacin [C19H23N4O3F2]+
Figure 8. Normalised ToF-SIMS depth profile analysis for a) p-tBCHA coated impregnated catheter, b) p-EGDPEA coated impregnated 
catheter, c) p-DEGMA coated impregnated catheter, and d) p-HPhOPA coated impregnated catheter. Normalised ion intensities for ions 
characteristic of the polymer coatings, the antimicrobials and silicone are shown. 
catheters or coating polymers did not cause inappropriate 
macrophage activation.
Upon LPS stimulation, macrophages alone (i.e. in the absence of 
catheters) produced TNF-α and IL-6 (Figure 9b-c), as expected. 
Significantly lower TNF-α and IL-6 production was seen by LPS-
stimulated macrophages in all catheter samples (uncoated and 
coated) (Figure 9b-c and Figure SI17), indicating that these samples 
were suppressing the normal inflammatory response. Further work 
would be necessary to determine the cause of this effect. 
Materials and Methods
General information. All polymerisation reactions were carried 
out under an atmosphere of argon using degassed monomer 
solutions. Degassing was carried out by bubbling argon through 
the monomer solution for 40 minutes immediately before use. 
Monomers and 2,2’-Azobis(2-methylpropionitrile) (AIBN) were 
purchased from Sigma-Aldrich and were used as received. All 
temperatures are referred to the temperatures of the oil baths 
used. Nuclear magnetic resonance (NMR) spectra were 
recorded on a Bruker AV400 (400.3 MHz) spectrometer at 
ambient temperature; chemical shifts are quoted in parts per 
million (ppm) and were referenced as follows: chloroform-d, 
7.26 ppm; benzene-d6 7.16 ppm for 1H NMR data.22 Coupling 
constants (J) are quoted in Hertz. Gel Permeation 
Chromatography (GPC) was carried out on a Polymer Labs GPC 
50 with 2 × PLgel Mixed-D columns and N,N-
dimethylformamide containing 0.1 wt% LiBr eluent. GPC 
calibration was carried out using poly(methyl methacrylate).
Polymerisation Reactions. All polymerisation reactions were 
carried out under an atmosphere of argon using degassed 
monomer solutions. Degassing was carried out by bubbling 
argon through the monomer solution for 40 minutes 
immediately before use. Monomers and 2,2’-Azobis(2-
methylpropionitrile) (AIBN) were purchased from Sigma-Aldrich 
and were used as received. All temperatures are referred to the 
temperatures of the oil baths used. Nuclear magnetic 
resonance (NMR) spectra were recorded on a Bruker AV400 
(400.3 MHz) spectrometer at ambient temperature; chemical 
shifts are quoted in parts per million (ppm) and were referenced 
as follows: chloroform-d, 7.26 ppm; benzene-d6 7.16 ppm for 
1H NMR data.22 Coupling constants (J) are quoted in Hertz. Gel 
Permeation Chromatography (GPC) was carried out on a 
Polymer Labs GPC 50 with 2 × PLgel Mixed-D columns and N,N-
dimethylformamide containing 0.1 wt% LiBr eluent. GPC 
calibration was carried out using poly(methyl methacrylate).
Antimicrobial Impregnation of Catheters. Silicone catheter  
tubing with a lumen diameter of 3.2 mm (Appleton Woods) was 
impregnated with sparfloxacin (SIGMA), triclosan (CIBA) and 
rifampicin (SIGMA) dissolved in chloroform to give 
concentrations of 1%, 1% and 0.2% respectively (Figure 4), as 
described previously.16
Coating of Catheters. Catheters were cut into sections 
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measuring 1 cm in length. These were then attached to a 21 gauge needle by piercing the catheter wall with the needle and 
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Figure 9. Effect of catheter coatings on primary human monocyte-derived macrophages. a) Schematic representation of experimental 
procedure for macrophage-catheter assays for cytokine determination. b-c) TNF-α and IL-6 production from macrophages that had been 
incubated with coated and uncoated plain catheters for b) 24 h (unstimulated) and c) followed by stimulation with 100 ng/ml LPS for 24 h 
(LPS-stimulated). Graphs represent mean ± SEM for n=3 (3 independent experiments using 3 separate donors). ANOVA with Tukey’s multiple 
comparison post-test conducted, *, p≤0.05, **, p≤0.01, and ***, p≤0.001. Blue symbols denote values that were below the standard range 
of the assay. Red symbols denote values that were above the standard range of the assay.
immersed by hand into a monomer solution of desired 
concentration (5 wt% or 1 wt%) in toluene for 1 s before being 
removed and left to dry under ambient conditions for 15 
minutes. This procedure was repeated twice before the 
catheter sections were placed under vacuum (<1 mbar) for 24 
h. Coating thickness was determined using a JEOL JSM-6490LV 
SEM using an accelerator voltage of 10 kV. Prior to analysis, 
coated samples were fractured after immersion in liquid 
nitrogen to expose the sample cross-section. Samples were 
mounted on carbon tape and gold coated using a Polaron 
SC7640 sputter coater, sputter time was 90 s, plasma current 
was 18-19 mA and a base chamber pressure of 0.6 mbar was 
achieved prior to coating.
Liquid chromatography mass spectrometry. Liquid 
chromatography mass spectrometry (LC-MS) was carried out on 
a ThermoFisher Exactive using a Sunfire C18 column stationary 
phase. Mobile phase was gradient elution from 95:5 0.1% NH3 
in H2O:CH3CN to 5:95 0.1% NH3 in H2O: CH3CN with a flow rate 
of 0.800 mL/min. Experiment stop time was 10.00 min
Time-of-flight secondary ion mass spectrometry. Dual beam 
depth profiling Time-of-flight secondary ion mass spectrometry 
(ToF-SIMS) measurements were conducted using a ToF-SIMS IV 
(IONTOF GmbH) instrument operated using a 25 kV Bi3+ primary 
ion source in combination with a 10 kV Arn+ sputter beam.  
Samples were scanned with a random raster over an area of 200 
× 200 µm. Positive secondary ion spectra were collected. Owing 
to the non-conductive nature of the samples, a low energy (20 
eV) electron flood gun was applied to provide charge 
compensation.
Serial Plate Transfer Test Assay. Test bacteria, methicillin 
resistant Staphylococcus aureus (MRSA) and extended 
spectrum beta-lactamases producing E. coli, were isolated from 
patients with CAUTI. MRSA was sensitive to rifampicin and 
triclosan, but resistant to sparfloxacin. E. coli was resistant to 
both rifampicin and sparfloxacin but susceptible to triclosan. 
Minimum inhibitory concentrations were determined by agar 
incorporation or in the case of rifampicin, by Etest (AB Biodisk, 
Solna, Sweden).  A serial transfer of the material to fresh plates 
will show how long the material produces a zone of inhibition 
(Serial Plate Transfer Test, SPTT).23 Mueller Hinton agar (Oxoid) 
plates were seeded with the test bacteria (A630 0.6, ~1 × 107 
cfu/mL) and impregnated silicone catheters with and without a 
coating were placed in triplicate on their surfaces and incubated 
overnight. Zones of inhibition were measured with calipers and 
the catheters were transferred to a fresh seeded plate and 
incubated at 37oC for 24 h. The process was repeated for up to 
10 days.
tK100 Assay. The plain and test catheters were immersed in a 
suspension (approximately 1 × 108 cfu/mL) of early log phase 
test bacteria and incubated at 37 °C for 1 h for attachment to 
take place. After rinsing to remove unattached bacteria, 
triplicates of discs were placed in diluted Tryptone Soya Broth 
(Oxoid) for up to 72 h, the dilution necessary for survival of 
attached bacteria to controls without planktonic multiplication, 
being found by experiment for each test isolate. At intervals of 
0, 24, 48 and 72 h, after rinsing and medium replacement each 
day, triplicates of catheters were removed and sonicated (50 Hz 
for 20 min) and surviving colonies plate - counted.
Generation of Monocyte-derived Macrophages. Monocyte-
derived macrophages were generated from buffy coats (Blood 
Transfusion Service, Sheffield, UK). Peripheral blood 
mononuclear cells (PBMCs) were isolated by density gradient 
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centrifugation using Histopaque-1077 (Sigma-Aldrich, UK). The 
PBMC layer was collected, washed and the monocyte fraction 
(CD14+ cells) was obtained by positive selection using human 
CD14 MicroBeads and LS MACS columns (Miltenyi Biotec, UK), 
following the manufacturer’s instructions. Purified monocytes 
were re- suspended in RPMI complete medium RPMI 1640 
(Sigma-Aldrich, UK) containing 15% human AB serum (Sigma-
Aldrich, UK), 2 mM GlutaMAX (Gibco, UK), 10 mM HEPES 
(Invitrogen, UK) and 50 ng/mL recombinant human macrophage 
colony stimulating factor (rhM-CSF, premium grade, Miltenyi 
Biotec, UK) and plated on ultra-low attachment 24-well flat 
bottom plates (Corning incorporated, USA) at a density of 1 x 
106 monocytes/500 µL. On Day 3, 500 µL per well of fresh RPMI 
complete medium containing 50 ng/mL rhM-CSF was added. 
Macrophages were harvested on Day 6 and used for assays with 
catheters.
Macrophage Response to Catheters. Catheters were placed in 
a 24-well tissue culture-treated (TC) plate (Costar, UK) and UV-
sterilised for 30 min. Day 6 macrophages were harvested, 
washed once with RPMI complete medium, counted, and 
seeded in the 24-well TC plate containing sterilised catheters at 
2.5 x 105 cells/750 µL/well in RPMI complete medium 
containing 50 ng/mL rhM-CSF. The volume of culture medium 
was sufficient to completely submerge the catheters. Cells were 
incubated with catheters for 24 h at 37oC, 5% CO2 in a 
humidified incubator. The following day, supernatants were 
removed from each well and stored at -20oC for cytokine 
determination (referred to in the text as “unstimulated 
samples”). 100 ng/mL ultrapure LPS from E. coli (Invivogen, UK) 
in fresh RPMI complete medium containing 50 ng/mL rhM-CSF 
was then added and the cells were re-incubated for a further 24 
h at 37oC, 5% CO2 in a humidified incubator. Supernatants from 
each well were collected the following day and stored at -20oC 
for cytokine analysis (referred to in the text as “LPS-stimulated 
samples”). Macrophage supernatants (appropriately diluted) 
were tested for presence of the cytokines TNF-α and IL-6 using 
DuoSet ELISA kits (R&D Systems, Inc., UK) following the 
manufacturer’s instructions. To assess macrophage viability, 
uncoated or coated antibiotic-impregnated catheters were 
placed in a 24-well tissue culture-treated (TC) plate (Eppendorf) 
and UV-sterilised for 30 min. Day 6 macrophages were 
harvested, washed 3 times with X-Vivo 15 serum-free medium 
(Lonza, UK), counted, and seeded in the 24-well TC plate 
containing sterilised catheters at 2.5 x 105 cells/1.5 mL/well in 
X-Vivo 15 medium containing 50 ng/mL rhM-CSF. The volume of 
culture medium was sufficient to completely submerge the 
catheters. Cells were incubated with catheters for 24 h at 37oC, 
5% CO2 in a humidified incubator. The following day, 750 µL of 
cell supernatants were removed from each well and stored at -
20oC for lactate dehydrogenase (LDH) determination (referred 
to in the text as “unstimulated samples”). 100 ng/mL ultrapure 
LPS from E. coli (Invivogen, UK) was then added and the cells 
with catheters were re-incubated for a further 24 h. The 
remaining 750 µL of cell supernatants from each well were 
collected the following day and stored at -20oC for LDH analysis 
(referred to in the text as “LPS-stimulated samples”). LDH in the 
supernatants was measured using the Cytotoxicity Detection Kit 
(LDH) kit (Roche, UK) as per the manufacturer’s instructions.
Statistical analysis. Linear regression analysis was carried out 
using the built-in linear model function in R version 3.6.1. 
Statistical analysis for macrophage cytokine responses was 
carried out in Prism v8.2.1, a repeated measures ANOVA with 
Tukey’s multiple comparison post-test was used.
Conclusions
In summary, two different strategies for preventing bacterial biofilm 
formation on catheters have been combined. We have shown that 
multiple antimicrobials can be delivered through polyacrylate 
coatings on impregnated silicone catheters. The rate of delivery 
through the coating was modulated by the coating chemistry and 
thickness. The zone of inhibition and prevention of biofilm formation 
was not adversely affected on the optimised device after application 
of the anti-biofilm coating. Surface characterisation and depth 
profiling by ToF-SIMS confirmed the presence of the polymer 
coatings on the devices and demonstrated the ability of the 
antibiotics to permeate through the polyacrylate layer. No adverse 
immunological response was observed to the coatings. The multi-
functional nature of the device developed in the study makes it an 
important approach to combatting medical device associated 
infections. 
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